Features of Social Status and The Presence of Risk Factors in Lung Tuberculosis Patients with Diabetes Mellitus

Introduction. Despite the significant impact of diabetes mellitus on the development and more severe course of the tuberculosis process, there are currently other significant risk factors that receive insufficient attention.

The purpose of the study is to investigate the presence of significant risk factors and social status characteristics among patients with pulmonary tuberculosis combined with diabetes mellitus.

Materials and methods. A total of 322 patients with pulmonary tuberculosis were included in the study, which were divided into 2 groups: 1 — combination with diabetes mellitus (n = 173); 2 — without diabetes mellitus (n = 149).

Results. Thus, it was found that among patients with diabetes, pensioners are more likely to be sick, as well as those who have a permanent job, whereas the unemployed predominate in the group without diabetes. When studying other significant risk factors, it was noted that alcohol abuse and withdrawal from treatment are significantly more common among patients with tuberculosis in combination with diabetes mellitus.

Discussion. Thus, it is worth noting that tuberculosis is more severe in patients with diabetes mellitus, and it should also be noted that patients with diabetes mellitus are highly susceptible to other significant risk factors.

Conclusion. Diabetes mellitus is an important risk factor for the development and more severe course of pulmonary tuberculosis. However, other risk factors are currently receiving insufficient attention. In addition, the risk of developing and the course of tuberculosis may be influenced by the characteristics of social status, which differ between patients with pulmonary tuberculosis with and without diabetes mellitus.

1. Adane HT, Howe RC, Wassie L, Magee MJ. Diabetes mellitus is associated with an increased risk of unsuccessful treatment outcomes among drug-susceptible tuberculosis patients in Ethiopia: A prospective health facility-based study. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2023;31:100368. DOI: https://doi.org/10.1016/j.jctube.2023.100368.

2. Al Amri S, Singh J, Al Balushi L, Al Ghafri T, Al Balushi MN, Al Marbouai H, et al. Prevalence and associated factors of diabetes mellitus type 2 among tuberculosis patients in Muscat, Oman, 2017–2020. Oman Medical Journal. 2023;38(4):e526. DOI: https://doi.org/10.5001/omj.2023.82.

3. Li M, Chen T, Hua Z, Yan H, Wang D, Li Z, et al. Global, regional, and national prevalence of diabetes mellitus in patients with pulmonary tuberculosis: A systematic review and meta-analysis. Diabetology and Metabolic Syndrome. 2021;13(1):127. DOI: https://doi.org/10.1186/s13098-021-00743-3.

4. Chumovatov NV, Komissarova OG, Antonov NS, Sakharova GM. Modern issues of lung tuberculosis and diabetes mellitus on the tobacco consumption background in the world and the Russian Federation. Russian Journal of Preventive Medicine. 2024;27(4):97–102. (In Russ.). DOI: https://doi.org/10.17116/profmed20242704197.

5. Wang CS, Yang CJ, Chen HC, Chuang SH, Chong IW, Hwang JJ, et al. Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiology and Infection. 2009;137(2):203–210. DOI: https://doi.org/10.1017/S0950268808000782.

6. Shewade HD, Jeyashree K, Mahajan P, Shah AN, Kirubakaran R, Rao R, et al. Effect of glycemic control and type of diabetes treatment on unsuccessful TB treatment outcomes among people with TB-Diabetes: A systematic review. PLoS One. 2017;12(10):e0186697. DOI: https://doi.org/10.1371/journal.pone.0186697.

7. Anyanwu MO, Ajumobi OO, Afolabi NB, Usman A, Kehinde A. Diabetes mellitus and its associated factors among patients with tuberculosis attending directly observed treatment centres in Oyo State, Nigeria: A cross-sectional evaluation. BMJ Open. 2022;12(4): e059260. DOI: https://doi.org/10.1136/bmjopen-2021-059260.

8. Khattak M, Rehman AU, Muqaddas T, Hussain R, Rasool MF, Saleem Z, et al. Tuberculosis (TB) treatment challenges in TB-diabetes comorbid patients: A systematic review and meta-analysis. Annals of Medicine. 2024;56(1):2313683. DOI: https://doi.org/10.1080/07853890.2024.2313683.

9. Komissarova OG, Abdullaev RYu, Aleshina SV. Approaches to selection of optimal chemotherapy regimens in tuberculosis patients with concurrent diabetes mellitus. Tuberculosis and Lung Diseases. 2023; 101(5):31–35 (In Russ.). DOI: https://doi.org/10.58838/2075-1230-2023-101-5-31-35.

10. Al-Bari MAA, Peake N, Eid N. Tuberculosis-diabetes comorbidities: Mechanistic insights for clinical considerations and treatment challenges. World Journal of Diabetes. 2024;15(5):853–866. DOI: https://doi.org/10.4239/wjd.v15.i5.853.

11. van Crevel R, Critchley JA. The interaction of diabetes and tuberculosis: Translating research to policy and practice. Tropical Medicine and Infectious Disease. 2021;6(1):8. DOI: https://doi.org/10.3390/tropicalmed6010008.

12. Tulu B, Amsalu E, Zenebe Y, Abebe M, Fetene Y, Agegn M, et al. Diabetes mellitus and HIV infection among active tuberculosis patients in Northwest Ethiopia: Health facility-based cross-sectional study. Tropical Medicine and Health. 2021;49(1):68. DOI: https://doi.org/10.1186/s41182-021-00358-4.

13. Niazi AK, Kalra S. Diabetes and tuberculosis: A review of the role of optimal glycemic control. Journal of Diabetes and Metabolic Disorders. 2012;11(1):28. DOI: https://doi.org/10.1186/2251-6581-11-28.

14. Cáceres G, Calderon R, Ugarte-Gil C. Tuberculosis and comorbidities: Treatment challenges in patients with comorbid diabetes mellitus and depression. Therapeutic Advances in Infectious Disease. 2022;9:20499361221095831. DOI: https://doi.org/10.1177/20499361221095831.

15. Esmail A, Sabur NF, Okpechi I, Dheda K. Management of drug-resistant tuberculosis in special sub-populations including those with HIV co-infection, pregnancy, diabetes, organ-specific dysfunction, and in the critically ill. Journal of Thoracic Disease. 2018;10(5):3102–3118. DOI: https://doi.org/10.21037/jtd.2018.05.11.

16. Antonio-Arques V, Franch-Nadal J, Caylà JA. Diabetes and tuberculosis: A syndemic complicated by COVID-19. Medicina Clinica (English Edition). 2021;157(6):288–293. DOI: https://doi.org/10.1016/j.medcle.2021.04.006.

17. Pearson F, Huangfu P, McNally R, Pearce M, Unwin N, Critchley JA. Tuberculosis and diabetes: Bidirectional association in a UK primary care data set. Journal of Epidemiology and Community Health. 2019; 73(2):142–147. DOI: https://doi.org/10.1136/jech-2018-211231.

18. Oliveira Hashiguchi L, Cox SE, Edwards T, Castro MC, Khan M, Liverani M. How can tuberculosis services better support patients with a diabetes co-morbidity? A mixed methods study in the Philippines. BMC Health Services Research. 2023;23(1):1027. DOI: https://doi.org/10.1186/s12913-023-10015-7.

19. Zhao L, Gao F, Zheng C, Sun X. The impact of optimal glycemic control on tuberculosis treatment out-comes in patients with diabetes mellitus: Systematic review and meta-analysis. JMIR Public Health and Surveillance. 2024;10: e53948. DOI: https://doi.org/10.2196/53948.

20. Milice DM, Macicame I, L Peñalvo J. The collaborative framework for the management of tuberculosis and type 2 diabetes syndemic in low- and middle-income countries: A rapid review. BMC Public Health. 2024; 24(1):738. DOI: https://doi.org/10.1186/s12889-024-18256-9.

21. Komissarova OG, Abdullaev RYu, Konyaeva OO, Berezhnaya OO, Mikhaylovskiy AM. Tuberculosis prevalence, symptoms and treatment efficacy in diabetes patients. Vrach. 2017;(2):24–28. (In Russ.). EDN: https://elibrary.ru/YICFFF.

22. Workneh MH, Bjune GA, Yimer SA. Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic review. PLoS One. 2017;12(4):0175925. DOI: https://doi.org/10.1371/journal.pone.0175925.

23. Dousa KM, Hamad A, Albirair M, Al Soub H, Elzouki AN, Alwakeel MI, et al. Impact of diabetes mellitus on the presentation and response to treatment of adults with pulmonary tuberculosis in Qatar. Open Forum Infectious Diseases. 2018;6(1): ofy335. DOI: https://doi.org/10.1093/ofid/ofy335.

24. Critchley JA, Carey IM, Harris T, DeWilde S, Hosking FJ, Cook DG. Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study. Diabetes Care. 2018; 41(10):2127–2135. DOI: https://doi.org/10.2337/dc18–0287.

25. Sotgiu G, Centis R, D’ambrosio L, Migliori GB. Tuberculosis treatment and drug regimens. Cold Spring Harbor Perspectives in Medicine. 2015;5(5): a017822. DOI: https://doi.org/10.1101/cshperspect.a017822.